Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Performance Evaluation of the Beckman Coulter DxN VERIS Hepatitis B Virus (HBV) Assay in Comparison With the Abbott RealTime HBV Assay.

Annals of laboratory medicine - 1 Jan 2019

Park Joonhong, Cho Hanwool, Choi Seung Jun, Lee Gun Dong, Sin Sang Hyun, Ryu Ji Hyeong, Park Hye Sun, Lee Hyeyoung, Kim Yonggoo, Oh Eun Jee

Abstract excerpt

The detection and quantification of hepatitis B virus (HBV) DNA plays an important role in diagnosing and monitoring HBV infection as well as in assessing the therapeutic response. We compared the analytical performance of a random access, fully automated HBV assay-DxN VERIS Molecular Diagnostics System (Beckman Coulter, Brea, CA, USA)-with that of Abbott RealTime HBV assay (Abbott Laboratories, Des Plaines, IL,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to DNA, Viral
Share to Drug Resistance, Viral

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genotype

Share to Hepatitis B

Share to Hepatitis B virus

Share to Limit of Detection

Share to Reagent Kits, Diagnostic

Share to Real-Time Polymerase Chain Reaction

Source

Open in PubMed Open full text

Identifiers

PMID: 30215235
DOI: 10.3343/alm.2019.39.1.86
PMCID: PMC6143473

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Performance Evaluation of the Beckman Coulter DxN VERIS Hepatitis B Virus (HBV) Assay in Comparison With the Abbott RealTime HBV Assay.PMID 30215235Read ↗

Evaluation of a new random-access HBV DNA molecular assay: The VERIS HBV assay.Semantic proximity Read ↗

A European multicenter study on the analytical performance of the VERIS HBV assay.Semantic proximity Read ↗

Performances of NeuMoDx, a random-access system for HBV-DNA and HCV-RNA quantificationSemantic proximity Read ↗

Analytical performance of the VERIS MDx system HCV assay for detecting and quantifying HCV RNA.Semantic proximity Read ↗

Comparison of the Abbott RealTime HBV assay with the Roche Cobas AmpliPrep/Cobas TaqMan HBV assay for HBV DNA detection and quantification.Semantic proximity Read ↗

Performance Characteristics and Comparison of Abbott and artus Real-Time Systems for Hepatitis B Virus DNA QuantificationSemantic proximity Read ↗

A cost-effective SYBR Green based Real-Time PCR platform for reliable detection of Hepatitis B Virus: Establishment and clinical validationSemantic proximity Read ↗

Comparison of the AdvanSure HBV real-time PCR test with three other HBV DNA quantification assays.Semantic proximity Read ↗

Performance evaluation of the Aptima® HCV Quant Dx assay for hepatitis C virus (HCV) RNA detection and quantification in comparison to the Abbott RealTime HCV assay.Semantic proximity Read ↗

Clinical performance of the VERIS HCV assay for hepatitis C virus RNA quantification.Semantic proximity Read ↗

Prospective comparison of Abbott RealTime HBV DNA and Versant HBV DNA 3.0 assays for hepatitis B DNA quantitation: impact on HBV genotype monitoring.Semantic proximity Read ↗

Evaluation of the Abbott investigational use only RealTime hepatitis C virus (HCV) assay and comparison to the Roche TaqMan HCV analyte-specific reagent assay.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.